<code id='14E4A89AC0'></code><style id='14E4A89AC0'></style>
    • <acronym id='14E4A89AC0'></acronym>
      <center id='14E4A89AC0'><center id='14E4A89AC0'><tfoot id='14E4A89AC0'></tfoot></center><abbr id='14E4A89AC0'><dir id='14E4A89AC0'><tfoot id='14E4A89AC0'></tfoot><noframes id='14E4A89AC0'>

    • <optgroup id='14E4A89AC0'><strike id='14E4A89AC0'><sup id='14E4A89AC0'></sup></strike><code id='14E4A89AC0'></code></optgroup>
        1. <b id='14E4A89AC0'><label id='14E4A89AC0'><select id='14E4A89AC0'><dt id='14E4A89AC0'><span id='14E4A89AC0'></span></dt></select></label></b><u id='14E4A89AC0'></u>
          <i id='14E4A89AC0'><strike id='14E4A89AC0'><tt id='14E4A89AC0'><pre id='14E4A89AC0'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:372
          Nathan Guo, left, and his wife Ada Lio encourage their 17-month-old son, Lucas Guo, to take steps in his gate trainer at their home in Somerville, MA on February 16, 2024. Lucas has one of the world's rarest diseases, ZTTK Syndrome
          Lucas Guo, a boy with a rare neurological condition called ZTTK, is encouraged by his father, Nathan Guo, and mother, Ada Lio, to take some steps. Craig F. Walker/The Boston Globe

          SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by himself. He babbles but can’t say words. He struggles to chew and swallow. He gets most of his nutrition through a feeding tube attached to his belly.

          Lucas has one of the world’s rarest diseases, ZTTK syndrome, a complex neurological disorder caused by a genetic mutation. Scientists have documented only about 60 cases worldwide and estimate that, at most, it afflicts several hundred people — far too few to encourage drug makers to find a treatment.

          advertisement

          That economic reality has driven Lucas’s parents, Ada Lio and Nathan Guo, to take things into their own hands. Working through a small foundation, they are trying to raise $10 million to develop a treatment or cure for ZTTK in five years.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Wegovy’s successful heart trial raises vital question about weight loss
          Wegovy’s successful heart trial raises vital question about weight loss

          BloombergAlandmarkstudythatfoundtheblockbusterobesitydrugWegovyreducesthechanceofheartproblemsaddsur

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Biotech investment managers search for lucrative opportunities

          Fromleft,RodNathan,portfoliomanagerandpartnerofJ.Goldman&Co.;ARKInvestsenioranalystAliUrman;andP